Citation Impact
Citing Papers
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Biosynthesis of biotin and lipoic acid
2001
Targeting hypoxia in cancer therapy
2011 Standout
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
2002
Bacillus lipopeptides: versatile weapons for plant disease biocontrol
2008 Standout
The Effect of Converting from Pravastatin to Simvastatin on the Pharmacodynamics of Warfarin
1999
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
The Mycobacterium tuberculosis CysQ phosphatase modulates the biosynthesis of sulfated glycolipids and bacterial growth
2011 StandoutNobel
Human Liver Expression of CYP2C8: Gender, Age, and Genotype Effects
2010
In vivo toxicity studies of fusarium mycotoxins in the last decade: A review
2015 Standout
HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins
2000
Disulfonimide‐Catalyzed Asymmetric Vinylogous and Bisvinylogous Mukaiyama Aldol Reactions
2010 StandoutNobel
Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin
1999
The Regulation of Sulfur Metabolism in Mycobacterium tuberculosis
2011 StandoutNobel
Gramicidin S identified as a potent inhibitor for cytochrome bd‐type quinol oxidase
2008 StandoutNobel
Vascular endothelial growth factor in eye disease
2008 Standout
Bacillomycin D: an iturin with antifungal activity against Aspergillus flavus
2001
Involvement of Cell Junctions in Hepatocyte Culture Functionality
2006
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
The chemistry and biotransformation of tea constituents
2011
‘Fire and forget?’ — pharmacological considerations in coronary care
1999
Statin-Associated Myopathy with Normal Creatine Kinase Levels
2002 Standout
Mycobacterium tuberculosis Rv3406 Is a Type II Alkyl Sulfatase Capable of Sulfate Scavenging
2013 StandoutNobel
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Involvement of human cytochromes P450 (CYP) in the reductive metabolism of AQ4N, a hypoxia activated anthraquinone DI-N-oxide prodrug
1998
Metabolism and Drug Interactions of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors in Transplant Patients
1998
Drug Targets in Mycobacterial Sulfur Metabolism
2007
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Comparative pharmacology of rosuvastatin
2003
Antibacterial drug discovery in the resistance era
2016 StandoutNature
Bacillus subtilis antibiotics: structures, syntheses and specific functions
2005
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Rv2131c fromMycobacterium tuberculosisIs a CysQ 3′-Phosphoadenosine-5′-phosphatase
2008 StandoutNobel
Mycosubtilin Overproduction by Bacillus subtilis BBG100 Enhances the Organism's Antagonistic and Biocontrol Activities
2005
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Statins Have Biphasic Effects on Angiogenesis
2002
Safety and Toxicology of Magnolol and Honokiol
2018 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Disulfonimid‐katalysierte asymmetrische vinyloge und bisvinyloge Mukaiyama‐Aldolreaktionen
2010 StandoutNobel
Development and Applications of Disulfonimides in Enantioselective Organocatalysis
2015 StandoutNobel
PLEIOTROPIC EFFECTS OF STATINS
2004 Standout
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants
2015 Standout
III Diretrizes Brasileiras Sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia
2001 Standout
Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers
2013 StandoutNobel
The Reciprocal Interactions between Polyphenols and Gut Microbiota and Effects on Bioaccessibility
2016 Standout
Apparent Catalytic Generation of Chiral Metal Enolates: Enantioselective Dienolate Additions to Aldehydes Mediated by Tol-BINAP·Cu(II) Fluoride Complexes
1998
New Targets and Screening Approaches in Antimicrobial Drug Discovery
2005
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Tailoring the volatility and stability of oligopeptides
2017 StandoutNobel
Treatment of Relapsing Paralysis in Experimental Encephalomyelitis by Targeting Th1 Cells through Atorvastatin
2003
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
3.6. Subacute and Subchronic Toxicity
2005
The Vinylogous Aldol Reaction: A Valuable, Yet Understated Carbon−Carbon Bond-Forming Maneuver
2000 Standout
Works of Armin Kern being referenced
Discovery of Riociguat (BAY 63‐2521): A Potent, Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension
2009
Rhizocticin A, an antifungal phosphono-oligopeptide of Bacillus subtilis ATCC 6633: biological properties
1990
The use of Long-term Hepatocyte Cultures for Detecting Induction of Drug Metabolising Enzymes: The Current Status
1999
Metabolic products from microorganisms. 230. Amiclenomycin-peptides, new antimetabolites of biotin. Taxonomy, fermentation and biological properties.
1985
Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved.
1997
Biotransformation of cerivastatin in mice, rats, and dogs in vivo.
1998
Amiclenomycin Peptides ‐ Isolation and Structure Elucidation of New Biotin Antimetabolites
1985